Top of this page
Skip navigation, go straight to the content

ucb-usa.com UCB in the U.S. UCB in the U.S.
 

About UCB in the United States

UCB is a global biopharmaceutical company focused on severe diseases that have significant unmet needs. By putting patients at the heart of everything we do, we enable people to live their best lives, delivering impactful solutions patients value.


At UCB, we come together every day to work, laser-focused, on a simple question: How will this create value for people living with severe diseases? Patient value is not just what we say, but how we how we live. It is our culture of care, embodied by our patient value strategy. That’s because how we do business – from discovery to development to delivery – has been transformed and redesigned around the patient and their individual experience. Patients are at the heart of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience beyond the medicine. By fulfilling our commitment, driving innovation, and providing patients a meaningful experience, more impactful solutions are on the horizon.


With a team of approximately 7,500 employees and operations in nearly 40 countries, we are a global biopharmaceutical company investing about a quarter of our revenue in cutting-edge scientific research to meet unmet patient needs. Global headquarters are in Brussels, Belgium, with U.S. headquarters in Atlanta, Georgia. Additional U.S. sites include global clinical development in Raleigh, North Carolina, our policy office in Washington, D.C., and research supporting UCB’s pipeline in Boston, Massachusetts and Seattle, Washington. We also have an office in Durham, North Carolina as part of our acquisition of Element Genomics and a Solution Accelerator on the Georgia Tech Campus in Atlanta. 

 

 

 
 
 
image description

Disease Areas

image description

UCB is committed to these disease states globally.

U.S. Leadership

image description

History

image description